Is AbbVie (ABBV) Still Worth Considering After Recent Share Price Pullback? Simply Wall St 22:59 Fri, 08 May
AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard FiercePharma 15:09 Fri, 08 May
AbbVie Korea holds ovarian cancer awareness campaign on World Ovarian Cancer Day Korea Biomedical Review 04:54 Fri, 08 May
AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines. Barchart 20:01 Thu, 07 May
AbbVie to Present at the Bank of America Securities Healthcare Conference PR Newswire (Press Release) 13:03 Wed, 06 May
Clio Health Champions: Madhuri Shah, Head of Marketing – Vyalev, AbbVie Muse by Clio 14:02 Tue, 05 May
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week® PR Newswire (Press Release) 13:07 Tue, 05 May
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook The Motley Fool 21:52 Mon, 04 May
US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23) The Tribune, California 17:49 Mon, 04 May
Should AbbVie’s (ABBV) Immunology Strength and Raised Outlook Offset Earnings Dip for Investors? Simply Wall St 02:56 Thu, 30 Apr
AbbVie Is Looking To Business Development To Backstop I&I Strength Scrip Pharma Intelligence 22:14 Wed, 29 Apr
AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde FiercePharma 19:58 Wed, 29 Apr
AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength Benzinga 19:55 Wed, 29 Apr Article paywall
AbbVie, Roche cut donations despite strong revenue growth in Korea in 2025 Korea Biomedical Review 02:20 Wed, 29 Apr
AbbVie Seeks Pan-KRAS Position With Kestrel Financing And Option Deal Scrip Pharma Intelligence 22:29 Tue, 28 Apr
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata AbbVie (Press Release) 13:02 Tue, 28 Apr
AbbVie's Planned $1B-Plus Research Triangle Campus Development Buoys Improved Life Sciences Outlook Bisnow 23:03 Mon, 27 Apr
AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease PR Newswire (Press Release) 13:05 Mon, 27 Apr
AbbVie Announces $1.4 Billion North Carolina Campus To Expand U.S. Pharmaceutical Manufacturing Capacity Pharmaceutical Online 13:04 Mon, 27 Apr
FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs FiercePharma 16:49 Fri, 24 Apr
AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug Benzinga 13:52 Fri, 24 Apr Article paywall
AbbVie expands US footprint with new $1.4 billion manufacturing campus European Pharmaceutical Review 11:23 Fri, 24 Apr
